27667559|t|Effects of an early intervention using human amniotic epithelial cells in a COPD rat model
27667559|a|The study aimed to investigate the effect of an early intervention using human amniotic epithelial cell (hAEC) in a rat model of chronic obstructive pulmonary disease (COPD). Twenty-four specific pathogen-free Wistar rats were randomized to the control, COPD, and COPD + hAEC groups. COPD was established by intratracheal LPS injection combined with smoke fumigation over 30 days. On the first day of model establishment rats in the AEC group also received intratracheal instillation of 500,000 hAECs isolated from the placenta of healthy donors. The mean linear intercept (MLI) and mean alveolar number (MAN) were used to assess the degree of lung emphysema. IL-8 was measured using a radioimmunoassay, surfactant protein D (SP-D) was measured by ELISA, and matrix metalloproteinase (MMP)2 and MMP8 expression was assessed by PCR. Smoke fumigation combined to LPS injection successfully established a COPD rat model with significant emphysema and airway inflammation, elevated MLI and MAN, elevated systemic and lung tissue levels of IL-8 and SP-D (P<0.05), and high expression of MMP2 and MMP8. Rats in the COPD + hAEC group exhibited alleviated lung damage, MLI and MAN (P<0.05), reduced systemic and lung tissue levels of IL-8 and SP-D (P<0.05) and MMP2 and MMP8 expression (P<0.05). Early intervention using hAECs could delay disease progression in rats with COPD.
27667559	0	7	Effects	T080	C1280500
27667559	20	32	intervention	T061	C0184661
27667559	39	44	human	T016	C0086418
27667559	45	53	amniotic	T018	C0002630
27667559	54	70	epithelial cells	T025	C0014597
27667559	76	80	COPD	T047	C0024117
27667559	81	84	rat	T015	C0034716
27667559	85	90	model	T075	C0026336
27667559	95	100	study	T062	C2603343
27667559	110	121	investigate	T169	C1292732
27667559	126	132	effect	T080	C1280500
27667559	145	157	intervention	T061	C0184661
27667559	164	169	human	T016	C0086418
27667559	170	178	amniotic	T018	C0002630
27667559	179	194	epithelial cell	T025	C0014597
27667559	196	200	hAEC	T025	C0014597
27667559	207	210	rat	T015	C0034716
27667559	211	216	model	T075	C0026336
27667559	220	257	chronic obstructive pulmonary disease	T047	C0024117
27667559	259	263	COPD	T047	C0024117
27667559	278	300	specific pathogen-free	T001	C0162470
27667559	301	312	Wistar rats	T015	C0034716
27667559	318	328	randomized	T062,T170	C0206034
27667559	336	343	control	T096	C0009932
27667559	345	349	COPD	T047	C0024117
27667559	355	359	COPD	T047	C0024117
27667559	362	366	hAEC	T025	C0014597
27667559	367	373	groups	T078	C0441833
27667559	375	379	COPD	T047	C0024117
27667559	399	412	intratracheal	T169	C1555389
27667559	413	416	LPS	T109	C0023810
27667559	441	446	smoke	T131	C0037366
27667559	447	457	fumigation	T068	C0016804
27667559	466	470	days	T079	C0439228
27667559	485	488	day	T079	C0439228
27667559	492	497	model	T075	C0026336
27667559	512	516	rats	T015	C0034716
27667559	524	527	AEC	T025	C0014597
27667559	528	533	group	T078	C0441833
27667559	548	574	intratracheal instillation	T169	C1555389
27667559	586	591	hAECs	T025	C0014597
27667559	610	618	placenta	T018	C0032043
27667559	622	629	healthy	T080	C3898900
27667559	630	636	donors	T098	C0013018
27667559	642	663	mean linear intercept	T081	C1444754
27667559	665	668	MLI	T081	C1444754
27667559	674	694	mean alveolar number	T081	C0237753
27667559	696	699	MAN	T081	C0237753
27667559	735	749	lung emphysema	T047	C0034067
27667559	751	755	IL-8	T116,T129	C0079633
27667559	777	793	radioimmunoassay	T059	C0034580
27667559	795	815	surfactant protein D	T116,T123	C0084692
27667559	817	821	SP-D	T116,T123	C0084692
27667559	839	844	ELISA	T059	C0014441
27667559	850	881	matrix metalloproteinase (MMP)2	T116,T126	C0172537
27667559	886	890	MMP8	T116,T126	C0172956
27667559	891	901	expression	T045	C1171362
27667559	918	921	PCR	T063	C0032520
27667559	923	928	Smoke	T131	C0037366
27667559	929	939	fumigation	T068	C0016804
27667559	952	955	LPS	T109	C0023810
27667559	993	997	COPD	T047	C0024117
27667559	998	1001	rat	T015	C0034716
27667559	1002	1007	model	T075	C0026336
27667559	1025	1034	emphysema	T047	C0034067
27667559	1039	1058	airway inflammation	T046	C0021368
27667559	1060	1068	elevated	T080	C3163633
27667559	1069	1072	MLI	T081	C1444754
27667559	1077	1080	MAN	T081	C0237753
27667559	1082	1090	elevated	T080	C3163633
27667559	1091	1099	systemic	T169	C0205373
27667559	1104	1108	lung	T023	C0024109
27667559	1109	1115	tissue	T024	C0040300
27667559	1116	1122	levels	T080	C0441889
27667559	1126	1130	IL-8	T116,T129	C0079633
27667559	1135	1139	SP-D	T116,T123	C0084692
27667559	1159	1169	expression	T045	C1171362
27667559	1173	1177	MMP2	T116,T126	C0172537
27667559	1182	1186	MMP8	T116,T126	C0172956
27667559	1188	1192	Rats	T015	C0034716
27667559	1200	1204	COPD	T047	C0024117
27667559	1207	1211	hAEC	T025	C0014597
27667559	1212	1217	group	T078	C0441833
27667559	1228	1238	alleviated	T080	C0392756
27667559	1239	1243	lung	T023	C0024109
27667559	1244	1250	damage	T037	C0010957
27667559	1252	1255	MLI	T081	C1444754
27667559	1260	1263	MAN	T081	C0237753
27667559	1274	1281	reduced	T080	C0392756
27667559	1282	1290	systemic	T169	C0205373
27667559	1295	1299	lung	T023	C0024109
27667559	1300	1306	tissue	T024	C0040300
27667559	1307	1313	levels	T080	C0441889
27667559	1317	1321	IL-8	T116,T129	C0079633
27667559	1326	1330	SP-D	T116,T123	C0084692
27667559	1344	1348	MMP2	T116,T126	C0172537
27667559	1353	1357	MMP8	T116,T126	C0172956
27667559	1358	1368	expression	T045	C1171362
27667559	1385	1397	intervention	T061	C0184661
27667559	1404	1409	hAECs	T025	C0014597
27667559	1422	1441	disease progression	T046	C0242656
27667559	1445	1449	rats	T015	C0034716
27667559	1455	1459	COPD	T047	C0024117